
Olink’s shares took a tumble by 1.7% following the announcement of a formal probe initiated by the UK’s antitrust authority into the company’s proposed $3.1 billion sale to Thermo Fisher.
The Competition and Markets Authority (CMA) of the UK disclosed the commencement of a Phase 1 review of the merger, with a decision deadline set for July 8.
This move by the CMA comes after its earlier announcement in February, indicating its scrutiny of the Olink/Thermo Fisher consolidation. The regulatory scrutiny is not confined to the UK alone, as German regulators are also closely examining the transaction.
Related: UK Competition Regulator Probes Thermo Fisher’s $3.1B Purchase of Olink
While Thermo Fisher had previously stated its confidence in closing the Olink acquisition by mid-2024, the timing might face potential delays, particularly with the looming July 8 deadline set by the UK’s regulatory body.
The acquisition agreement, struck in October, entails Thermo Fisher acquiring Sweden-based Olink at $26 per share. Despite the regulatory turbulence, Thermo Fisher’s shares saw a contrasting rise of 2.3% on Friday, reflecting a market sentiment potentially aligned with its reassurance regarding the deal’s progress.
Source: MSN
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas